OR WAIT 15 SECS
Natural Alternatives International says that as the sole U.S. patent holder of CarnoSyn beta-alanine, it has a responsibility to ensure that consumers are taking the ingredient properly in order to reap its muscle-building benefits.
Natural Alternatives International Inc. (NAI; Carlsbad, CA), announced that it will be launching an education campaign that aims to inform manufacturers and consumers about the proper loading period and dosing of CarnoSyn beta-alanine. NAI says that as the sole U.S. patent holder of CarnoSyn beta-alanine, it has a responsibility to ensure that CarnoSyn beta-alanine is being taken properly to ensure its purported muscle-building benefits.
NAI notes that while there are currently more than 55 scientific studies supporting the benefits of beta-alanine, it is necessary for consumers to take the proper dosage to achieve those benefits. NAI recommends that consumers load a minimum of 90 g for a period of 28 days; for maximum benefits, consumers should load 179 g for 28 days. According to NAI, the proper dosing regimen is roughly 3.2-6.4 g/day; however, consumers do not need to take the maximum dose all at once, it says. Instead, consumers can stack doses by taking a pre- or post-workout product, a standalone product, or a combination. Regardless, it says, CarnoSyn must be taken daily to see benefits.
Roger Harris, PhD, is the biochemist who first analyzed the connection between beta-alanine and carnosine, a dipeptide molecule made up of the amino acids beta-alanine and histidine. In an NAI press release, Harris explained the necessity for consumer education about dosing. “It’s incredibly important that those taking CarnoSyn betaâalanine understand that the proven benefits do not apply to them if they are underâdosing,” he said. “It’s up to the CarnoSyn brand partners to formulate their supplements with the correct dose of the ingredient. Every brand partner should make a clear statement that 90â179 g must be taken over a period of 28 days in order to achieve proven results.”
Kenneth Wolf, president, NAI, added: “Our mission with this initiative is to lead the charge on ensuring our partners are clearly communicating the correct loading and dosing information.”
More details about the initiative and loading information can be found on CarnoSyn’s website.